drugset / Trial / NCT00370084

Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia

NCT00370084

Phase 1/2 Completed 25 enrolled Forest Laboratories
RandomizedCrossoverQuadruple-blindTreatment

Summary

Itopride is a new compound that is already marketed in Japan and in some countries of Eastern Europe under the name of Ganaton. It is used to treat symptoms associated with gastroparesis. Due to inadequate gastric emptying, these patients often have symptoms of bloating, nausea and vomiting following ingestion of a meal. The goal of this study is to evaluate the effects of Itopride on gastric motor function and glycemia in patients with diabetes.

Timeline

Start
2005-03
Primary completion
2006-05
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Itopride Small molecule 200 mg Oral

Indications